Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMBINE: Nicotinamide and Lanthanum Carbonate in CKD
NCT02258074Phase 2Completed
- Sponsor
- Cleveland Clinic
- Start
- Mar 2015
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nicotinamide, lanthanum carbonate in chronic kidney disease (CKD), sponsored by Cleveland Clinic. Started Mar 2015; status: completed.
02
Drugs
nicotinamidelanthanum carbonate
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT02258074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02258074.